Stonegate initiates coverage on incannex healthcare inc. (ixhl)

Dallas, texas--(newsfile corp. - october 2, 2024) - incannex healthcare inc. (nasdaq: ixhl): stonegate capital partners initiates their coverage on incannex healthcare inc. (nasdaq: ixhl) to view the full announcement, including downloadable images, bios, and more, click here. key takeaways: advancing proprietary, synthetic first and best-in-class cannabinoid and psychedelic-assisted therapeutics conducting fda phase 2/3 trial, ihl-42x, for the treatment of obstructive sleep apnea (osa) ihl-42x pivotal phase 2 top-line data expected first half 2025 click image above to view full announcement.
IXHL Ratings Summary
IXHL Quant Ranking